Yeah, it's 'only' a central nervous system (CNS) drug. Imagine that's a piece of cake.
From the research report on NEU's own website : "The overall success rate for CNS drugs was 8%"
http://www.neurenpharma.com/ssl/cms/files_cms/172_NEU%200510%20-%20Update.pdf
Phew, the odds are only stacked 12:1 against NEU. Now that's what I call a punt!
Good luck to holders.
Yeah, it's 'only' a central nervous system (CNS) drug. Imagine...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.32 |
Change
-0.150(1.04%) |
Mkt cap ! $1.841B | |||
| Open | High | Low | Value | Volume |
| $14.47 | $14.53 | $14.22 | $2.734M | 190.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 854 | $14.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.33 | 400 | 9 |
View Market Depth
| Last trade - 13.29pm 03/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |